lister institute of preventive medicine(the)
lister institute of preventive medicine(the) Company Information
Company Number
00034479
Registered Address
10 norwich street, london, EC4A 1BD
Industry
Other research and experimental development on natural sciences and engineering
Other human health activities
Telephone
01923801886
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
-0%
lister institute of preventive medicine(the) Estimated Valuation
Pomanda estimates the enterprise value of LISTER INSTITUTE OF PREVENTIVE MEDICINE(THE) at £380.1k based on a Turnover of £595k and 0.64x industry multiple (adjusted for size and gross margin).
lister institute of preventive medicine(the) Estimated Valuation
Pomanda estimates the enterprise value of LISTER INSTITUTE OF PREVENTIVE MEDICINE(THE) at £0 based on an EBITDA of £-4.4m and a 3.87x industry multiple (adjusted for size and gross margin).
lister institute of preventive medicine(the) Estimated Valuation
Pomanda estimates the enterprise value of LISTER INSTITUTE OF PREVENTIVE MEDICINE(THE) at £100.1m based on Net Assets of £43.3m and 2.31x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Lister Institute Of Preventive Medicine(the) Overview
Lister Institute Of Preventive Medicine(the) is a live company located in london, EC4A 1BD with a Companies House number of 00034479. It operates in the other research and experimental development on natural sciences and engineering sector, SIC Code 72190. Founded in July 1891, it's largest shareholder is unknown. Lister Institute Of Preventive Medicine(the) is a mature, small sized company, Pomanda has estimated its turnover at £595k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Lister Institute Of Preventive Medicine(the) Health Check
Pomanda's financial health check has awarded Lister Institute Of Preventive Medicine(The) a 4 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 4 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
4 Weak
Size
annual sales of £595k, make it smaller than the average company (£2.6m)
£595k - Lister Institute Of Preventive Medicine(the)
£2.6m - Industry AVG
Growth
3 year (CAGR) sales growth of -11%, show it is growing at a slower rate (4.2%)
-11% - Lister Institute Of Preventive Medicine(the)
4.2% - Industry AVG
Production
with a gross margin of 40.8%, this company has a comparable cost of product (40.8%)
40.8% - Lister Institute Of Preventive Medicine(the)
40.8% - Industry AVG
Profitability
an operating margin of -737.1% make it less profitable than the average company (6%)
-737.1% - Lister Institute Of Preventive Medicine(the)
6% - Industry AVG
Employees
with 3 employees, this is below the industry average (34)
3 - Lister Institute Of Preventive Medicine(the)
34 - Industry AVG
Pay Structure
on an average salary of £37.3k, the company has an equivalent pay structure (£42.6k)
£37.3k - Lister Institute Of Preventive Medicine(the)
£42.6k - Industry AVG
Efficiency
resulting in sales per employee of £198.3k, this is more efficient (£78k)
£198.3k - Lister Institute Of Preventive Medicine(the)
£78k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Lister Institute Of Preventive Medicine(the)
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Lister Institute Of Preventive Medicine(the)
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Lister Institute Of Preventive Medicine(the)
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 173 weeks, this is more cash available to meet short term requirements (72 weeks)
173 weeks - Lister Institute Of Preventive Medicine(the)
72 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 0.4%, this is a lower level of debt than the average (35.2%)
0.4% - Lister Institute Of Preventive Medicine(the)
35.2% - Industry AVG
LISTER INSTITUTE OF PREVENTIVE MEDICINE(THE) financials
Lister Institute Of Preventive Medicine(The)'s latest turnover from December 2022 is £595 thousand and the company has net assets of £43.3 million. According to their latest financial statements, Lister Institute Of Preventive Medicine(The) has 3 employees and maintains cash reserves of £167 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 595,000 | 612,000 | 593,000 | 846,000 | 987,000 | 734,000 | 789,000 | 739,000 | 645,000 | 499,000 | 343,000 | 340,000 | 388,000 | 410,000 |
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | ||||||||||||||
| Gross Profit | ||||||||||||||
| Admin Expenses | ||||||||||||||
| Operating Profit | ||||||||||||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 402,000 |
| Pre-Tax Profit | -4,378,000 | 2,903,000 | 1,486,000 | 2,642,000 | -1,243,000 | -786,000 | -502,000 | -723,000 | -569,000 | -670,000 | -559,000 | -581,000 | -488,000 | -441,000 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -4,378,000 | 2,903,000 | 1,486,000 | 2,642,000 | -1,243,000 | -786,000 | -502,000 | -723,000 | -569,000 | -670,000 | -559,000 | -581,000 | -488,000 | -441,000 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | -4,378,000 | 2,903,000 | 1,486,000 | 2,642,000 | -1,243,000 | -786,000 | -502,000 | -723,000 | -569,000 | -670,000 | -559,000 | -581,000 | -488,000 | -441,000 |
| Employee Costs | 112,000 | 96,000 | 109,000 | 120,000 | 98,000 | 96,000 | 94,000 | 106,000 | 89,000 | 87,000 | 83,000 | 81,000 | 80,000 | 78,000 |
| Number Of Employees | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 43,294,000 | 47,597,000 | 44,858,000 | 43,226,000 | 40,824,000 | 43,583,000 | 41,492,000 | 38,568,000 | 37,296,000 | 37,250,000 | 33,965,000 | 31,802,000 | 33,344,000 | 31,019,000 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 43,294,000 | 47,597,000 | 44,858,000 | 43,226,000 | 40,824,000 | 43,583,000 | 41,492,000 | 38,568,000 | 37,296,000 | 37,250,000 | 33,965,000 | 31,802,000 | 33,344,000 | 31,019,000 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 9,000 | 20,000 | 9,000 | 9,000 | 48,000 | 0 | 14,000 | 17,000 | 36,000 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 6,000 | 5,000 | 26,000 | 8,000 | 2,000 | 3,000 | 184,000 | 1,000 | 0 | 8,000 | 0 | 0 | 0 | 22,000 |
| Cash | 167,000 | 283,000 | 132,000 | 303,000 | 69,000 | 133,000 | 193,000 | 155,000 | 1,441,000 | 650,000 | 241,000 | 231,000 | 241,000 | 205,000 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 173,000 | 288,000 | 158,000 | 311,000 | 80,000 | 156,000 | 386,000 | 165,000 | 1,489,000 | 658,000 | 255,000 | 248,000 | 277,000 | 227,000 |
| total assets | 43,467,000 | 47,885,000 | 45,016,000 | 43,537,000 | 40,904,000 | 43,739,000 | 41,878,000 | 38,733,000 | 38,785,000 | 37,908,000 | 34,220,000 | 32,050,000 | 33,621,000 | 31,246,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 50,000 | 73,000 | 88,000 | 73,000 | 62,000 | 98,000 | 64,000 | 32,000 | 263,000 | 429,000 | 28,000 | 233,000 | 25,000 | 15,000 |
| total current liabilities | 50,000 | 73,000 | 88,000 | 73,000 | 62,000 | 98,000 | 64,000 | 32,000 | 263,000 | 429,000 | 28,000 | 233,000 | 25,000 | 15,000 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 142,000 | 134,000 | 134,000 | 143,000 | 155,000 | 160,000 | 168,000 | 177,000 | 184,000 | 186,000 | 191,000 | 202,000 | 331,000 | 0 |
| total long term liabilities | 142,000 | 134,000 | 134,000 | 143,000 | 155,000 | 160,000 | 168,000 | 177,000 | 184,000 | 186,000 | 191,000 | 202,000 | 331,000 | 341,000 |
| total liabilities | 192,000 | 207,000 | 222,000 | 216,000 | 217,000 | 258,000 | 232,000 | 209,000 | 447,000 | 615,000 | 219,000 | 435,000 | 356,000 | 356,000 |
| net assets | 43,275,000 | 47,678,000 | 44,794,000 | 43,321,000 | 40,687,000 | 43,481,000 | 41,646,000 | 38,524,000 | 38,338,000 | 37,293,000 | 34,001,000 | 31,615,000 | 33,265,000 | 30,890,000 |
| total shareholders funds | 43,275,000 | 47,678,000 | 44,794,000 | 43,321,000 | 40,687,000 | 43,481,000 | 41,646,000 | 38,524,000 | 38,338,000 | 37,293,000 | 34,001,000 | 31,615,000 | 33,265,000 | 30,890,000 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | ||||||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 1,000 | -21,000 | 18,000 | -3,000 | -12,000 | -170,000 | 183,000 | -38,000 | 40,000 | -6,000 | -3,000 | -19,000 | 14,000 | 22,000 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | -23,000 | -15,000 | 15,000 | 11,000 | -36,000 | 34,000 | 32,000 | -231,000 | -166,000 | 401,000 | -205,000 | 208,000 | 10,000 | 15,000 |
| Deferred Taxes & Provisions | 8,000 | 0 | -9,000 | -12,000 | -5,000 | -8,000 | -9,000 | -7,000 | -2,000 | -5,000 | -11,000 | -129,000 | 331,000 | 0 |
| Cash flow from operations | ||||||||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | 0 | 0 | 0 | 0 | 1,223,000 | 541,000 | 0 | 0 | 9,360,000 | |||||
| Change in Investments | -4,303,000 | 2,739,000 | 1,632,000 | 2,402,000 | -2,759,000 | 2,091,000 | 2,924,000 | 1,272,000 | 46,000 | 3,285,000 | 2,163,000 | -1,542,000 | 2,325,000 | 31,019,000 |
| cash flow from investments | 4,303,000 | -2,739,000 | -1,632,000 | -2,402,000 | 3,982,000 | -1,550,000 | -2,924,000 | -1,272,000 | 9,314,000 | |||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 402,000 |
| cash flow from financing | -25,000 | -19,000 | -13,000 | -8,000 | -1,551,000 | 2,621,000 | 3,624,000 | 909,000 | 1,614,000 | 3,962,000 | 2,945,000 | -1,069,000 | 2,863,000 | 31,733,000 |
| cash and cash equivalents | ||||||||||||||
| cash | -116,000 | 151,000 | -171,000 | 234,000 | -64,000 | -60,000 | 38,000 | -1,286,000 | 791,000 | 409,000 | 10,000 | -10,000 | 36,000 | 205,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -116,000 | 151,000 | -171,000 | 234,000 | -64,000 | -60,000 | 38,000 | -1,286,000 | 791,000 | 409,000 | 10,000 | -10,000 | 36,000 | 205,000 |
lister institute of preventive medicine(the) Credit Report and Business Information
Lister Institute Of Preventive Medicine(the) Competitor Analysis
Perform a competitor analysis for lister institute of preventive medicine(the) by selecting its closest rivals and benchmarking them against 12 key performance metrics.
lister institute of preventive medicine(the) Ownership
LISTER INSTITUTE OF PREVENTIVE MEDICINE(THE) group structure
Lister Institute Of Preventive Medicine(The) has no subsidiary companies.
Ultimate parent company
LISTER INSTITUTE OF PREVENTIVE MEDICINE(THE)
00034479
lister institute of preventive medicine(the) directors
Lister Institute Of Preventive Medicine(The) currently has 15 directors. The longest serving directors include Professor Sir Alec Jeffreys (Jul 1995) and Mr Rory Guinness (Jun 1998).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Professor Sir Alec Jeffreys | 74 years | Jul 1995 | - | Director | |
| Mr Rory Guinness | 49 years | Jun 1998 | - | Director | |
| Professor Douglas Higgs | England | 73 years | Sep 2011 | - | Director |
| Mr Matthew Pintus | 67 years | Sep 2012 | - | Director | |
| Professor Wendy Bickmore | Scotland | 62 years | Sep 2013 | - | Director |
| Professor Rebecca Fitzgerald | England | 55 years | Sep 2015 | - | Director |
| Professor Judith Armitage | 73 years | Sep 2015 | - | Director | |
| Sir Adrian Bird | 76 years | Sep 2015 | - | Director | |
| Professor John Iredale | 63 years | Sep 2017 | - | Director | |
| Professor Dame Pamela Shaw | England | 69 years | Sep 2018 | - | Director |
P&L
December 2022turnover
595k
-3%
operating profit
-4.4m
0%
gross margin
40.9%
+4.59%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
43.3m
-0.09%
total assets
43.5m
-0.09%
cash
167k
-0.41%
net assets
Total assets minus all liabilities
Similar Companies
lister institute of preventive medicine(the) company details
company number
00034479
Type
Private Ltd By Guarantee w/o Share Cap
industry
72190 - Other research and experimental development on natural sciences and engineering
86900 - Other human health activities
incorporation date
July 1891
age
133
accounts
Small Company
ultimate parent company
previous names
N/A
incorporated
UK
address
10 norwich street, london, EC4A 1BD
last accounts submitted
December 2022
lister institute of preventive medicine(the) Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to lister institute of preventive medicine(the). Currently there are 1 open charges and 0 have been satisfied in the past.
lister institute of preventive medicine(the) Companies House Filings - See Documents
| date | description | view/download |
|---|
